VERA THERAPEUTICS INC (VERA) Forecast, Price Target & Analyst Ratings

NASDAQ:VERA • US92337R1014

Current stock price

43.45 USD
-0.91 (-2.05%)
At close:
43.61 USD
+0.16 (+0.37%)
Pre-Market:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VERA THERAPEUTICS INC (VERA).

Forecast Snapshot

Consensus Price Target

Price Target
$79.72
+ 83.47% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$1.35
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$79.72
Upside
+ 83.47%
From current price of $43.45 to mean target of $79.72, Based on 20 analyst forecasts
Low
$35.35
Median
$79.56
High
$115.50

Price Target Revisions

1 Month
4.53%
3 Months
5.94%

Price Target Summary

20 Wall Street analysts provided a forecast for the next 12 months for VERA. The average price target is 79.72 USD. This implies a price increase of 83.47% is expected in the next year compared to the current price of 43.45.
The average price target has been revised upward by 5.94% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

VERA Current Analyst RatingVERA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

VERA Historical Analyst RatingsVERA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
85.00%
VERA was analyzed by 20 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about VERA.
In the previous month the buy percentage consensus was at a similar level.
VERA was analyzed by 20 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-11Wolfe ResearchUpgrade Peer Perform -> Outperform
2026-03-02HC Wainwright & Co.Maintains Buy -> Buy
2025-12-19JP MorganMaintains Overweight -> Overweight
2025-12-19Goldman SachsMaintains Buy -> Buy
2025-12-19B of A SecuritiesMaintains Buy -> Buy
2025-12-11WedbushMaintains Neutral -> Neutral
2025-12-08Evercore ISI GroupMaintains Outperform -> Outperform
2025-12-05TD CowenMaintains Buy -> Buy
2025-11-10HC Wainwright & Co.Maintains Buy -> Buy
2025-11-07JP MorganMaintains Overweight -> Overweight
2025-10-16B of A SecuritiesInitiate Buy
2025-08-07JP MorganMaintains Overweight -> Overweight
2025-08-04Wolfe ResearchDowngrade Outperform -> Peer Perform
2025-06-02ScotiaBankMaintains Sector Outperform -> Sector Outperform
2025-06-02HC Wainwright & Co.Maintains Buy -> Buy
2025-05-07Cantor FitzgeraldMaintains Overweight -> Overweight
2025-05-07WedbushMaintains Neutral -> Neutral
2025-03-04JP MorganMaintains Overweight -> Overweight
2025-02-27GuggenheimMaintains Buy -> Buy
2025-02-04Wolfe ResearchInitiate Outperform
2024-11-21Wells FargoInitiate Overweight
2024-11-08WedbushMaintains Neutral -> Neutral
2024-11-05JP MorganMaintains Overweight -> Overweight
2024-10-28GuggenheimMaintains Buy -> Buy
2024-10-16ScotiaBankInitiate Sector Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$1.35
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-67.10%
Number of Analysts
12

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.56%
EPS (3 Months)
-7.11%

Next Earnings Summary

VERA is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -1.35 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
VERA revenue by date.VERA revenue by date.
N/AN/AN/A
472.48%		N/A
159.42%		N/A
59.30%		N/A
32.47%		N/A
23.22%		N/A
9.67%		N/A
12.02%
EBITDA
YoY % growth
VERA ebitda by date.VERA ebitda by date.
-11.08M-47.81M
-331.50%		-34.22M
28.43%		N/A
-126.53%		N/A
-27.63%		-167.065M
-68.85%		-315.005M
-88.55%		N/A
-8.58%		N/A
40.67%		N/A
241.78%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
VERA ebit by date.VERA ebit by date.
-11.59M-48.06M
-314.67%		-34.4M
28.42%		-90.9M
-164.24%		-102.012M
-12.22%		-167.17M
-63.87%		-315.473M
-88.71%		N/A
-15.78%		N/A
40.22%		N/A
137.18%		N/A
322.75%		N/A
75.00%		N/A
28.63%		N/A
28.07%		N/A
17.46%
Operating Margin
VERA operating margin by date.VERA operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
VERA eps by date.VERA eps by date.
N/AN/A-13.71-3.35
75.57%		-2.31
31.04%		-2.75
-19.05%		-4.66
-69.45%		N/A
-14.50%		N/A
40.25%		N/A
141.95%		N/A
339.89%		N/A
46.47%		N/A
3.46%		N/A
23.15%		N/A
15.76%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-1.35
-67.10%		-1.42
-18.41%		-1.37
-8.80%		-1.18
15.46%		-1.22
9.57%		-0.99
30.37%		-0.65
52.38%		-0.20
83.07%
Revenue
Q2Q % growth		8.873M41.761M30.67M43.351M64.145M
622.92%		99.081M
137.26%
EBITDA
Q2Q % growth		-83.379M
-46.00%		-86.967M
-8.79%		-76.368M
8.65%		-52.48M
44.01%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-94.594M
-65.39%		-99.775M
-24.50%		-98.494M
-17.35%		-83.692M
11.16%		-86.128M
8.95%		-70.568M
29.27%		-48.437M
50.82%		-14.917M
82.18%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

VERA Yearly Revenue VS EstimatesVERA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B 2B
VERA Yearly EPS VS EstimatesVERA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 -5 10 -10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
31.75%
EPS Next 5 Year
30.94%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
42.97%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

VERA THERAPEUTICS INC / VERA Forecast FAQ

What is the price target for VERA stock?

20 analysts have analysed VERA and the average price target is 79.72 USD. This implies a price increase of 83.47% is expected in the next year compared to the current price of 43.45.

Can you provide the upcoming earnings date for VERA THERAPEUTICS INC?

VERA THERAPEUTICS INC (VERA) will report earnings on 2026-05-04.

Can you provide the consensus estimates for VERA THERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of VERA THERAPEUTICS INC (VERA) is -1.35 USD and the consensus revenue estimate is 0 USD.

How do analysts rate VERA THERAPEUTICS INC (VERA)?

The consensus rating for VERA THERAPEUTICS INC (VERA) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.